Chula Vista, CA, United States of America

Erik Boman

USPTO Granted Patents = 3 


Average Co-Inventor Count = 13.6

ph-index = 3

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2010-2011

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Erik Boman

Introduction

Erik Boman is a notable inventor based in Chula Vista, California. He has made significant contributions to the field of biotechnology, particularly in the development of cytokine inhibitors. With a total of three patents to his name, Boman's work focuses on creating low molecular weight compounds that serve as anti-inflammatory agents.

Latest Patents

One of Erik Boman's latest patents involves cytokine inhibitors. This invention provides low molecular weight compounds that are useful as cytokine inhibitors and compositions thereof. In particular, these compounds are designed to be effective as anti-inflammatory agents. The patent also outlines methods for the preparation of such agents and their application in preventing or treating conditions mediated by cytokines, such as arthritis.

Career Highlights

Erik Boman has established himself as a key figure in the biotechnology sector. His innovative work has led to advancements in treatments for inflammatory conditions, showcasing his commitment to improving healthcare through scientific research.

Collaborations

Erik collaborates with talented professionals in his field, including Susana Conde Ceide and Russell Dahl. Their combined expertise contributes to the success of their projects and the advancement of their research.

Conclusion

Erik Boman's contributions to the field of biotechnology, particularly through his patents on cytokine inhibitors, highlight his role as an influential inventor. His work continues to pave the way for new treatments in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…